Trial NCT00396812

View at ClinicalTrials.gov 
Org. Study IDs: DAIT ARA04

Last trial update was posted on 2013-02-12

MeSH Interventions

Rituximab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

The perceived risk-benefit ratio for individuals with early active RA

Limitations And Caveats

The trial terminated early due to rituximab's risk-benefit ratio for individuals with early active Rheumatoid Arthritis. Mechanistic samples were not processed and corresponding endpoints were not assessed. Only descriptive statistics are presented.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID